Related Experiment Videos
Third complement component in cerebrospinal fluid in neuro-Behçet's syndrome. Conversion patterns by crossed
Journal of the Neurological Sciences
|April 1, 1979
Summary
Complement system activation in neuro-Behçet's syndrome (nB) involves C3 protein conversion in cerebrospinal fluid (CSF). This suggests complement consumption via the alternative pathway and blood-CSF barrier inflammation in nB patients.
Area of Science:
- Neurology
- Immunology
- Biochemistry
Background:
- Neuro-Behçet's syndrome (nB) is a neurological complication of Behçet's disease.
- The role of the complement system in nB pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the presence and significance of complement C3 conversion products in the cerebrospinal fluid (CSF) of nB patients.
- To correlate C3 conversion with inflammatory markers and blood-CSF barrier integrity in nB.
Main Methods:
- Cerebrospinal fluid (CSF) specimens from 10 nB patients were analyzed.
- Crossed immunoelectrophoresis was used to detect C3 and C4 complement protein conversion products.
- Levels of alpha 2-macroglobulin and IgA were measured as indicators of blood-CSF barrier function.
Main Results:
- C3 conversion products were detected in 4 out of 13 CSF specimens from nB patients.
- CSF with C3 conversion showed elevated C3 protein levels and signs of inflammation, including increased alpha 2-macroglobulin and IgA.
- Blood-CSF barrier involvement was indicated by these elevated protein levels.
Conclusions:
- Complement C3 activation and consumption occur in the CSF of some nB patients.
- The alternative complement pathway may be involved in nB pathogenesis.
- C3 conversion in CSF correlates with inflammation and blood-CSF barrier dysfunction in nB.